CN102579576A - 川芎茶调颗粒提取物及其制剂制备方法 - Google Patents
川芎茶调颗粒提取物及其制剂制备方法 Download PDFInfo
- Publication number
- CN102579576A CN102579576A CN2012100447124A CN201210044712A CN102579576A CN 102579576 A CN102579576 A CN 102579576A CN 2012100447124 A CN2012100447124 A CN 2012100447124A CN 201210044712 A CN201210044712 A CN 201210044712A CN 102579576 A CN102579576 A CN 102579576A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- gained
- herba
- extract
- nanofiltration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 103
- 239000000284 extract Substances 0.000 title claims abstract description 91
- 239000008187 granular material Substances 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 127
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 53
- 238000001728 nano-filtration Methods 0.000 claims abstract description 45
- 239000000843 powder Substances 0.000 claims abstract description 40
- 239000000341 volatile oil Substances 0.000 claims abstract description 40
- 239000000463 material Substances 0.000 claims abstract description 32
- 239000003814 drug Substances 0.000 claims abstract description 30
- 238000001694 spray drying Methods 0.000 claims abstract description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 75
- 239000012528 membrane Substances 0.000 claims description 62
- 230000008569 process Effects 0.000 claims description 35
- 239000007788 liquid Substances 0.000 claims description 34
- 239000000243 solution Substances 0.000 claims description 33
- 235000019830 sodium polyphosphate Nutrition 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 12
- 230000008719 thickening Effects 0.000 claims description 12
- 239000007901 soft capsule Substances 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 8
- 239000000385 dialysis solution Substances 0.000 claims description 6
- 239000007902 hard capsule Substances 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 abstract description 19
- 238000001914 filtration Methods 0.000 abstract description 15
- 239000000706 filtrate Substances 0.000 abstract description 9
- 239000004615 ingredient Substances 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 3
- 235000014347 soups Nutrition 0.000 abstract 3
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 30
- 230000004907 flux Effects 0.000 description 17
- 239000012567 medical material Substances 0.000 description 16
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 238000012360 testing method Methods 0.000 description 9
- 238000009472 formulation Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 5
- 229960004949 glycyrrhizic acid Drugs 0.000 description 5
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 5
- 239000001685 glycyrrhizic acid Substances 0.000 description 5
- 235000019410 glycyrrhizin Nutrition 0.000 description 5
- -1 micropill Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 238000005265 energy consumption Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 238000001223 reverse osmosis Methods 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 235000018927 edible plant Nutrition 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 3
- 229940114124 ferulic acid Drugs 0.000 description 3
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 3
- 235000001785 ferulic acid Nutrition 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229960001375 lactose Drugs 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000008542 thermal sensitivity Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 244000115658 Dahlia pinnata Species 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000005514 two-phase flow Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
温度(℃) | 浓缩液量(kg) | 透析液量(kg) | 平均膜通量(L/m2.h) |
32 | 3.2 | 16.7 | 24.5 |
34 | 4.2 | 15.8 | 25.6 |
36 | 3.6 | 16.4 | 28.0 |
38 | 3.3 | 16.6 | 28.8 |
压力(bar) | 浓缩液量(kg) | 透析液量(kg) | 平均膜通量(L/m2.h) |
15 | 5.8 | 14.2 | 23.4 |
17 | 2.2 | 17.7 | 26.4 |
19 | 3.6 | 16.4 | 28.0 |
时间(min) | 乙腈(%) | 0.05%甲酸(%) |
0 | 5 | 95 |
85 | 28 | 72 |
100 | 45 | 55 |
105 | 50 | 50 |
135 | 65 | 35 |
Claims (25)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210044712 CN102579576B (zh) | 2012-02-27 | 2012-02-27 | 川芎茶调颗粒提取物及其制剂制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210044712 CN102579576B (zh) | 2012-02-27 | 2012-02-27 | 川芎茶调颗粒提取物及其制剂制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102579576A true CN102579576A (zh) | 2012-07-18 |
CN102579576B CN102579576B (zh) | 2013-12-18 |
Family
ID=46469178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210044712 Active CN102579576B (zh) | 2012-02-27 | 2012-02-27 | 川芎茶调颗粒提取物及其制剂制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102579576B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103263468A (zh) * | 2013-05-30 | 2013-08-28 | 钦州市钦南区人民医院 | 一种治疗结膜炎的中药 |
CN103784505A (zh) * | 2014-02-24 | 2014-05-14 | 福州华凯医药科技有限公司 | 川芎茶调制剂 |
CN103800438A (zh) * | 2014-02-24 | 2014-05-21 | 福州华凯医药科技有限公司 | 川芎茶调制剂和制法 |
CN103816223A (zh) * | 2014-02-24 | 2014-05-28 | 贵州威门药业股份有限公司 | 无糖型川芎茶调颗粒 |
CN104069175A (zh) * | 2014-06-17 | 2014-10-01 | 王庚禹 | 一种用于制备川芎茶调制剂的提取物 |
CN104306440A (zh) * | 2014-09-22 | 2015-01-28 | 海南葫芦娃制药有限公司 | 一种川芎茶调散及其制备方法 |
CN104940431A (zh) * | 2015-06-23 | 2015-09-30 | 湖南安邦制药有限公司 | 一种川芎茶调制剂 |
CN108404140A (zh) * | 2016-06-01 | 2018-08-17 | 湖南安邦制药有限公司 | 一种挥发油的包合工艺 |
CN115813992A (zh) * | 2022-11-30 | 2023-03-21 | 四川彩虹制药有限公司 | 荆防颗粒中荆芥的提取工艺 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062157A (zh) * | 2007-05-29 | 2007-10-31 | 南京中山制药有限公司 | 枳术颗粒的制备工艺 |
CN101829501A (zh) * | 2010-04-21 | 2010-09-15 | 周滨江 | 用于中药提取分离和浓缩的联合膜过滤方法 |
CN102198049A (zh) * | 2011-05-10 | 2011-09-28 | 浙江中医药大学 | 中药制取方法及其装置 |
-
2012
- 2012-02-27 CN CN 201210044712 patent/CN102579576B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062157A (zh) * | 2007-05-29 | 2007-10-31 | 南京中山制药有限公司 | 枳术颗粒的制备工艺 |
CN101829501A (zh) * | 2010-04-21 | 2010-09-15 | 周滨江 | 用于中药提取分离和浓缩的联合膜过滤方法 |
CN102198049A (zh) * | 2011-05-10 | 2011-09-28 | 浙江中医药大学 | 中药制取方法及其装置 |
Non-Patent Citations (3)
Title |
---|
吴清: "《230种中药颗粒剂和胶囊剂制备关键技术》", 31 January 2009, 化学工业出版社 * |
杨祖金等: "纳滤技术在中药浓缩中的应用", 《中药材》 * |
邵江娟等: "纳滤分离技术在制备中草药产品中的应用研究进展", 《中国医药工业杂志》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103263468A (zh) * | 2013-05-30 | 2013-08-28 | 钦州市钦南区人民医院 | 一种治疗结膜炎的中药 |
CN103784505A (zh) * | 2014-02-24 | 2014-05-14 | 福州华凯医药科技有限公司 | 川芎茶调制剂 |
CN103800438A (zh) * | 2014-02-24 | 2014-05-21 | 福州华凯医药科技有限公司 | 川芎茶调制剂和制法 |
CN103816223A (zh) * | 2014-02-24 | 2014-05-28 | 贵州威门药业股份有限公司 | 无糖型川芎茶调颗粒 |
CN103784505B (zh) * | 2014-02-24 | 2016-08-24 | 北京三泉医药技术有限公司 | 川芎茶调制剂 |
CN103800438B (zh) * | 2014-02-24 | 2017-02-15 | 北京三泉医药技术有限公司 | 川芎茶调制剂和制法 |
CN104069175A (zh) * | 2014-06-17 | 2014-10-01 | 王庚禹 | 一种用于制备川芎茶调制剂的提取物 |
CN104306440A (zh) * | 2014-09-22 | 2015-01-28 | 海南葫芦娃制药有限公司 | 一种川芎茶调散及其制备方法 |
CN104306440B (zh) * | 2014-09-22 | 2018-02-09 | 海南葫芦娃药业集团股份有限公司 | 一种川芎茶调散及其制备方法 |
CN104940431A (zh) * | 2015-06-23 | 2015-09-30 | 湖南安邦制药有限公司 | 一种川芎茶调制剂 |
CN108404140A (zh) * | 2016-06-01 | 2018-08-17 | 湖南安邦制药有限公司 | 一种挥发油的包合工艺 |
CN115813992A (zh) * | 2022-11-30 | 2023-03-21 | 四川彩虹制药有限公司 | 荆防颗粒中荆芥的提取工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN102579576B (zh) | 2013-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579576B (zh) | 川芎茶调颗粒提取物及其制剂制备方法 | |
CN100503626C (zh) | 应用膜分离技术从肉苁蓉中生产含有苯乙醇苷的原料及其制备方法 | |
CN101396384B (zh) | 一种积雪草提取物及其制备方法 | |
CN101129463B (zh) | 一种丹参注射液的制备方法 | |
CN102146109A (zh) | 高纯度栀子苷的制备方法 | |
CN101284120A (zh) | 平消制剂的制备方法 | |
CN101480484B (zh) | 一种防风通圣散制剂的制备方法 | |
CN101607049B (zh) | 制备痔炎消制剂的药材提取液分离浓缩方法 | |
CN101623313A (zh) | 一种补血中药制剂的制备方法 | |
CN103371424A (zh) | 一种中药饮料浓缩液的制备方法 | |
CN102258659B (zh) | 藿香正气口服液的制备方法 | |
CN101371882A (zh) | 一种茵陈蒿汤制剂的制备方法 | |
CN104224867B (zh) | 一种金钱草无糖颗粒及其制备方法 | |
CN101690757A (zh) | 一种牛黄上清制剂的制备方法 | |
CN100500183C (zh) | 一种治疗妇女经期疾病的中药合剂的制备方法 | |
CN104888021A (zh) | 一种维c银翘片 | |
CN104069140B (zh) | 一种制备金钱草浸膏及其颗粒的方法 | |
CN102631386B (zh) | 柴胡解热镇痛制剂及其制备工艺 | |
CN101422522B (zh) | 一种中药制剂的制备方法 | |
CN102319308B (zh) | 小儿清热止咳口服液的制备方法 | |
CN101623332B (zh) | 夏天无总生物碱酸盐冻干物的制备方法及所得冻干物的应用 | |
CN1449806A (zh) | 中药六味地黄制剂的生产工艺 | |
CN105311119A (zh) | 夏天无总生物碱精制物、制备方法、药物组合物及应用 | |
CN109745368B (zh) | 一种升麻配方颗粒的制备方法 | |
CN101396546A (zh) | 一种葛根汤制剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Extraction and preparation of Chuanxiong chatiao granules Effective date of registration: 20210113 Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210723 Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chuanxiong chatiao granule extract and preparation method thereof Effective date of registration: 20210819 Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000011 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220601 Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000011 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chuanxiong chatiao granule extract and its preparation method Effective date of registration: 20220719 Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2022520000033 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230523 Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2022520000033 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Extraction of Chuanxiong Chadiao Granules and Preparation Method of Their Preparations Effective date of registration: 20230530 Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2023520000021 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2023520000021 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Extraction of Chuanxiong Tea Tiao Granules and Preparation Method of Their Formulations Granted publication date: 20131218 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2024520000019 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |